Published Oct 30, 2026, 2:30 AM ET · Updated 15 days ago · 2 sources
Sanofi Raises Profit Forecast on Blockbuster Dupixent Sales
bloomberg
·
Original Report
INFERY
Sanofi raised its forecasts for sales and profit this year for a second straight quarter on rising demand for its top-selling skin and asthma drug Dupixent.